Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors
Clinical wisdom rather than formal evidence and guidelines recommendations appears to guide the management of PCC/PPGLs among Italian HCPs. International, multi-institutional clinical trials designed to take into account the rarity of PCCs/PPGLs are needed to generate high-level evidence and provide guidance for standard clinical practice.
Authors
- Salvatore Tafuto (ORCID: https://orcid.org/0000-0002-3019-354X)
- Mauro Cives (ORCID: https://orcid.org/0000-0002-3013-1816)
- Elisabetta Dell’Unto (ORCID: https://orcid.org/0009-0004-8128-1111)
- Francesco Panzuto (ORCID: https://orcid.org/0000-0003-2789-4289)
- Leonardo Della Sala
- Antonella Lucia Marretta
- Nevena Mikovic (ORCID: https://orcid.org/0000-0002-0102-531X)
- A Carli
- Elisa Andrini (ORCID: https://orcid.org/0000-0003-2952-1507)
- Erica Pietroluongo (ORCID: https://orcid.org/0000-0003-2370-2139)
- Ilaria Mascagni (ORCID: https://orcid.org/0009-0008-3088-1255)
Institutions
- University of Verona (IT)
- Humanitas University (IT)
- European Neuroendocrine Tumor Society (DE)
- Federico II University Hospital (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- University of Bari Aldo Moro (IT)
- University of Naples Federico II (IT)
- University of Genoa (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fendo.2025.1687570
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00